Prevalence of hepatitis C infection among the general population and high-risk groups in the EU/EEA: A systematic review update

Abstract excerpt

<title>Abstract</title> <p>Background: Although significant improvement in efficacy measured by a sustained virological response, the high acquisition costs of direct-acting antivirals limit the access for patients and influence the costs of healthcare resource utilisation in hepatitis C. It is important to have the latest estimates of prevalence, especially in high-risk groups, for cost of illness, cost-effectiv...

Topics

Open a Topic to create a Post that cites this publication.

• Hepacivirus
• Hepatitis C
• Incidence
• Iran
• Population Surveillance
• Prevalence
• Risk Assessment
• Risk Factors

Identifiers and source

Literature Corpus work

812e1db1-f188-5932-8386-8f4f09aae184

DOI

10.21203/rs.2.9311/v4